CVS Health Available-for-Sale Debt Securities - Amortized Cost (Due Within One Year) increased by 1.8% to $850.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 28.7%, from $1.19B to $850.00M. This is a positive signal — higher values indicate stronger performance for this metric.
Higher levels indicate strong short-term liquidity, while lower levels might suggest a reliance on other funding sources or a strategy to reinvest in longer-term assets.
This metric measures the amortized cost of available-for-sale debt securities that are scheduled to mature within one ye...
Standard metric for all financial institutions to demonstrate short-term solvency and cash flow management.
afs_debt_securities_amortized_cost_1y| Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.23B | $1.22B | $1.30B | $1.41B | $1.30B | $1.27B | $1.26B | $1.37B | $819.00M | $1.19B | $961.00M | $835.00M | $850.00M |
| QoQ Change | — | -0.6% | +6.4% | +8.7% | -7.6% | -2.4% | -0.9% | +8.2% | -40.0% | +45.5% | -19.4% | -13.1% | +1.8% |
| YoY Change | — | — | — | +15.0% | +6.8% | -2.0% | -10.6% | +4.7% | -35.7% | -5.5% | -29.6% | +2.0% | -28.7% |